These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 22986151)

  • 1. Transferrin-cisplatin specifically deliver cisplatin to HepG2 cells in vitro and enhance cisplatin cytotoxicity.
    Luo LZ; Jin HW; Huang HQ
    J Proteomics; 2012 Dec; 77():237-50. PubMed ID: 22986151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of cell death events induced by anti-neoplastic drugs cisplatin, paclitaxel and 5-fluorouracil on human hepatoma cell lines: Possible mechanisms of cell resistance.
    Brenes O; Arce F; Gätjens-Boniche O; Díaz C
    Biomed Pharmacother; 2007 Jul; 61(6):347-55. PubMed ID: 17399942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transferrin serves as a mediator to deliver organometallic ruthenium(II) anticancer complexes into cells.
    Guo W; Zheng W; Luo Q; Li X; Zhao Y; Xiong S; Wang F
    Inorg Chem; 2013 May; 52(9):5328-38. PubMed ID: 23586415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction of nanometer cisplatin core-ferritin (NCC-F) and proteomic analysis of gastric cancer cell apoptosis induced with cisplatin released from the NCC-F.
    Ji XT; Huang L; Huang HQ
    J Proteomics; 2012 Jun; 75(11):3145-57. PubMed ID: 22480910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of glutathione synthesis reverses Krüppel-like factor 4-mediated cisplatin resistance.
    Jia Y; Zhang W; Liu H; Peng L; Yang Z; Lou J
    Cancer Chemother Pharmacol; 2012 Feb; 69(2):377-85. PubMed ID: 21833590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterisation of cisplatin-induced transcriptomics responses in primary mouse hepatocytes, HepG2 cells and mouse embryonic stem cells shows conservation of regulating transcription factor networks.
    Rieswijk L; Lizarraga D; Brauers KJ; Kleinjans JC; van Delft JH
    Mutagenesis; 2014 Jan; 29(1):17-26. PubMed ID: 24280081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VCC-1 over-expression inhibits cisplatin-induced apoptosis in HepG2 cells.
    Zhou Z; Lu X; Zhu P; Zhu W; Mu X; Qu R; Li M
    Biochem Biophys Res Commun; 2012 Apr; 420(2):336-42. PubMed ID: 22425983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic growth-suppressive effects of quercetin and cisplatin on HepG2 human hepatocellular carcinoma cells.
    Zhao JL; Zhao J; Jiao HJ
    Appl Biochem Biotechnol; 2014 Jan; 172(2):784-91. PubMed ID: 24122665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increase the cisplatin cytotoxicity and cisplatin-induced DNA damage in HepG2 cells by XRCC1 abrogation related mechanisms.
    Zhang R; Niu Y; Zhou Y
    Toxicol Lett; 2010 Feb; 192(2):108-14. PubMed ID: 19853026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SC-III3, a novel scopoletin derivative, induces cytotoxicity in hepatocellular cancer cells through oxidative DNA damage and ataxia telangiectasia-mutated nuclear protein kinase activation.
    Zhao P; Chen L; Li LH; Wei ZF; Tong B; Jia YG; Kong LY; Xia YF; Dai Y
    BMC Cancer; 2014 Dec; 14():987. PubMed ID: 25527123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylated actinomycin D, a novel actinomycin D analog induces apoptosis in HepG2 cells through Fas- and mitochondria-mediated pathways.
    Chen Y; Liu J; Yuan B; Cao C; Qin S; Cao X; Bian G; Wang Z; Jiang J
    Mol Carcinog; 2013 Dec; 52(12):983-96. PubMed ID: 22821714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulated miR-182 increases drug resistance in cisplatin-treated HCC cell by regulating TP53INP1.
    Qin J; Luo M; Qian H; Chen W
    Gene; 2014 Apr; 538(2):342-7. PubMed ID: 24447717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclic GMP/protein kinase G type-Iα (PKG-Iα) signaling pathway promotes CREB phosphorylation and maintains higher c-IAP1, livin, survivin, and Mcl-1 expression and the inhibition of PKG-Iα kinase activity synergizes with cisplatin in non-small cell lung cancer cells.
    Wong JC; Bathina M; Fiscus RR
    J Cell Biochem; 2012 Nov; 113(11):3587-98. PubMed ID: 22740515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Curcumin reduces cisplatin-induced neurotoxicity in NGF-differentiated PC12 cells.
    Mendonça LM; da Silva Machado C; Teixeira CC; de Freitas LA; Bianchi Mde L; Antunes LM
    Neurotoxicology; 2013 Jan; 34():205-11. PubMed ID: 23036615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-193b acts as a cisplatin sensitizer via the caspase-3-dependent pathway in HCC chemotherapy.
    Yin W; Nie Y; Zhang Z; Xie L; He X
    Oncol Rep; 2015 Jul; 34(1):368-74. PubMed ID: 25997995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucocorticoid cotreatment induces apoptosis resistance toward cancer therapy in carcinomas.
    Herr I; Ucur E; Herzer K; Okouoyo S; Ridder R; Krammer PH; von Knebel Doeberitz M; Debatin KM
    Cancer Res; 2003 Jun; 63(12):3112-20. PubMed ID: 12810637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dexamethasone decreases hepatocellular carcinoma cell sensitivity to cisplatin-induced apoptosis.
    Yang N; Zhang H; Si-Ma H; Fu Y; Zhao W; Li D; Yang G
    Hepatogastroenterology; 2011; 58(110-111):1730-5. PubMed ID: 21940343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HCV core protein promotes hepatocyte proliferation and chemoresistance by inhibiting NR4A1.
    Tan Y; Li Y
    Biochem Biophys Res Commun; 2015 Oct; 466(3):592-8. PubMed ID: 26392314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cisplatin induces cell cycle arrest and senescence via upregulating P53 and P21 expression in HepG2 cells.
    Qu K; Lin T; Wei J; Meng F; Wang Z; Huang Z; Wan Y; Song S; Liu S; Chang H; Dong Y; Liu C
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Sep; 33(9):1253-9. PubMed ID: 24067199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement effect of adenovirus-mediated antisense c-myc and caffeine on the cytotoxicity of cisplatin in osteosarcoma cell lines.
    Xie XK; Yang DS; Ye ZM; Tao HM
    Chemotherapy; 2009; 55(6):433-40. PubMed ID: 19996588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.